Back close

Novel Targeted Chitosan based Therapeutic Polymeric Nanomedicines for Lung Cancer Applications

Start Date: Wednesday, Dec 01,2010

School: School of Nano Sciences

Project Incharge:Dr. R. Jayakumar
Funded by:DST
Novel Targeted Chitosan based Therapeutic Polymeric Nanomedicines for Lung Cancer Applications

This project aims to develop a synergistic collaboration between an active nanomedicine team from the Faculty of Pharmacy, University of Porto, Portugal and a strong nano medicine group at the Amrita Center for Nanosciences, AIMS, Kochi, India. The broad area of this targeted nanomedicine research is lung cancer, which is a very serious disease in both the collaborating countries. The project seeks to develop novel targeted nanosystems for delivery of anti-tumour medicines to non-small lung cancer cells.

The broad area of this targeted nanomedicine research is lung cancer, which is a very serious disease in both the collaborating countries. The project seeks to develop novel targeted nanosystems for delivery of anti-tumour medicines to non-small lung cancer cells.

Related Projects

Plasma Surface Modification of Nanostructured Surfaces of Marine Based Scaffolds and Membranes for Enhanced Bioactivity
Plasma Surface Modification of Nanostructured Surfaces of Marine Based Scaffolds and Membranes for Enhanced Bioactivity
Theragnostics, Re-generative Medicine and Stem Cell Using Cell-Targeted Nano-material
Theragnostics, Re-generative Medicine and Stem Cell Using Cell-Targeted Nano-material
Development of Natural Biopolymeric Hydrogel Bandages with NanoZnO/ Nanosuspensions of Herb Hemigraphis Ulternata for Wound Dressing
Development of Natural Biopolymeric Hydrogel Bandages with NanoZnO/ Nanosuspensions of Herb Hemigraphis Ulternata for Wound Dressing
Novel Target-Specific Multiplexed Nano- Phytomedicines for Cancer Therapy
Novel Target-Specific Multiplexed Nano- Phytomedicines for Cancer Therapy
Nano Toxicology and Nano Medicine – Phase II
Nano Toxicology and Nano Medicine – Phase II
Admissions Apply Now